Daewoong completes EMA application of ‘Nabota’
‘Nabota,’ a Daewoong Pharmaceutical’s botulinum toxin, will enter the European market.
EVOLUS, a European partner of Nabota, said it has completed a process of the marketing authorization application(MAA) of DWP-450(Nabota’s development name in the U.S. and Europe) as a forehead wrinkle removal ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
